| Anti-Chlamydia trachomatis MIF 1 (IgA)10338930331 | EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA | IV | 28/04/2035 |
| Anti-Toxoplasma gondii ELISA 2.0 (IgG)10338930339 | EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA | IV | 24/11/2035 |
| Anti-Treponema pallidum ELISA 2.0 (IgGM)10338930359 | EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA | IV | 10/08/2036 |
| DUE RETARDANTE PLUS10339360021 | Made in Italy Imp Com e Representação Ltda | IV | 24/12/2028 |
| DUE EXTASY PRIME10339360022 | Made in Italy Imp Com e Representação Ltda | IV | 04/02/2029 |
| LIAISON VCA IgG10339840159 | DIASORIN LTDA | IV | 22/12/2035 |
| LIAISON EBV IgM10339840160 | DIASORIN LTDA | IV | 02/03/2036 |
| LIAISON CONTROL VCA IgG10339840248 | DIASORIN LTDA | IV | 29/12/2035 |
| LIAISON CONTROL EBV IgM10339840251 | DIASORIN LTDA | IV | 02/03/2036 |
| LIAISON Control EBNA IgG10339840307 | DIASORIN LTDA | IV | 22/12/2035 |
| LIAISON EBNA IgG10339840308 | DIASORIN LTDA | IV | 22/12/2035 |
| ICE* Syphilis10339840322 | DIASORIN LTDA | IV | 01/08/2036 |
| Murex HIV Ag/Ab Combination10339840327 | DIASORIN LTDA | IV | 05/09/2036 |
| MUREX HTLV I+II10339840328 | DIASORIN LTDA | IV | 05/09/2036 |
| Murex anti-HBc (Total)10339840422 | DIASORIN LTDA | IV | 27/06/2036 |
| FAMÍLIA LIAISON HBc IgM10339840424 | DIASORIN LTDA | IV | 14/11/2026 |
| Família LIAISON Treponema Screen10339840425 | DIASORIN LTDA | IV | 14/11/2026 |
| LIAISON HBeAg10339840426 | DIASORIN LTDA | IV | 14/11/2026 |
| LIAISON Anti-HBe10339840427 | DIASORIN LTDA | IV | 14/11/2026 |
| LIAISON Anti-HBc10339840428 | DIASORIN LTDA | IV | 14/11/2026 |
| FAMÍLIA LIAISON® CMV IgG II10339840429 | DIASORIN LTDA | IV | 06/02/2037 |
| LIAISON® CMV IgM II10339840430 | DIASORIN LTDA | IV | 10/04/2027 |
| FAMÍLIA LIAISON® XL MUREX Anti-HBs10339840433 | DIASORIN LTDA | IV | 17/07/2027 |
| LIAISON® Toxo IgM10339840436 | DIASORIN LTDA | IV | 13/11/2027 |
| Família LIAISON® CMV IgG Avidity II10339840437 | DIASORIN LTDA | IV | 13/11/2027 |